218 related articles for article (PubMed ID: 2698296)
41. Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.
Friedemann T; Ying Y; Wang W; Kramer ER; Schumacher U; Fei J; Schröder S
Am J Chin Med; 2016; 44(5):907-25. PubMed ID: 27430912
[TBL] [Abstract][Full Text] [Related]
42. Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances.
Sayre LM; Wang FJ; Arora PK; Riachi NJ; Harik SI; Hoppel CL
J Neurochem; 1991 Dec; 57(6):2106-15. PubMed ID: 1940917
[TBL] [Abstract][Full Text] [Related]
43. [MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and parkinsonism].
Gao XM; Ku BS
Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):161-3. PubMed ID: 2686017
[No Abstract] [Full Text] [Related]
44. Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+ -induced neurodegeneration.
Cartelli D; Ronchi C; Maggioni MG; Rodighiero S; Giavini E; Cappelletti G
J Neurochem; 2010 Oct; 115(1):247-58. PubMed ID: 20649848
[TBL] [Abstract][Full Text] [Related]
45. The Essential Role of Drp1 and Its Regulation by S-Nitrosylation of Parkin in Dopaminergic Neurodegeneration: Implications for Parkinson's Disease.
Zhang Z; Liu L; Jiang X; Zhai S; Xing D
Antioxid Redox Signal; 2016 Oct; 25(11):609-622. PubMed ID: 27267045
[TBL] [Abstract][Full Text] [Related]
46. High-Resolution Respirometry Reveals MPP
Risiglione P; Leggio L; Cubisino SAM; Reina S; Paternò G; Marchetti B; Magrì A; Iraci N; Messina A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105548
[TBL] [Abstract][Full Text] [Related]
47. [Pathophysiology of Parkinson's disease: an update].
Tremblay L
Bull Acad Natl Med; 2010 Oct; 194(7):1321-31; discussion 1331-2. PubMed ID: 22043627
[TBL] [Abstract][Full Text] [Related]
48. Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease.
Ikeda H; Markey CJ; Markey SP
Brain Res; 1992 Mar; 575(2):285-98. PubMed ID: 1571786
[TBL] [Abstract][Full Text] [Related]
49. Theoretical studies on mechanism of MPTP action: ET interference by MPP+ (1-methyl-4-phenylpyridinium) with mitochondrial respiration vs. oxidative stress.
Kovacic P; Edwards WD; Ming G
Free Radic Res Commun; 1991; 14(1):25-32. PubMed ID: 2022343
[TBL] [Abstract][Full Text] [Related]
50. Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models.
Chattopadhyay M; Chowdhury AR; Feng T; Assenmacher CA; Radaelli E; Guengerich FP; Avadhani NG
J Biol Chem; 2019 Jun; 294(26):10336-10348. PubMed ID: 31113867
[TBL] [Abstract][Full Text] [Related]
51. Etiology of Parkinson's disease: current concepts.
Duvoisin RC
Clin Neuropharmacol; 1986; 9 Suppl 1():S3-21. PubMed ID: 2423234
[TBL] [Abstract][Full Text] [Related]
52. CDK5-USP30 signaling pathway regulates MAVS-mediated inflammation via suppressing mitophagy in MPTP/MPP
Ren Y; Wu X; Bai T; Yang N; Yuan Y; Xu L; Wen Y; Wen Y; Wang Z; Zhou L; Zou F; Li W
Ecotoxicol Environ Saf; 2024 Jul; 279():116446. PubMed ID: 38772138
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains.
Mizuno Y; Suzuki K; Sone N; Saitoh T
Neurosci Lett; 1987 Oct; 81(1-2):204-8. PubMed ID: 3501080
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871
[TBL] [Abstract][Full Text] [Related]
55. [Mitochondrial DNA and Parkinson disease. Methodologic review].
Pautot V; Macaigne C; Chariot P
Arch Anat Cytol Pathol; 1998; 46(4):261-8. PubMed ID: 9754389
[TBL] [Abstract][Full Text] [Related]
56. The genetics of Parkinson's disease: a reconsideration.
Golbe LI
Neurology; 1990 Oct; 40(10 Suppl 3):suppl 7-14; discussion 14-6. PubMed ID: 2215974
[No Abstract] [Full Text] [Related]
57. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism.
Ramsay RR; Salach JI; Dadgar J; Singer TP
Biochem Biophys Res Commun; 1986 Feb; 135(1):269-75. PubMed ID: 3485428
[TBL] [Abstract][Full Text] [Related]
58. Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.
Battino M; Littarru GP; Gorini A; Villa RF
Neurochem Res; 1996 Dec; 21(12):1505-14. PubMed ID: 8953566
[TBL] [Abstract][Full Text] [Related]
59. MPTP: insights into the etiology of Parkinson's disease.
Langston JW
Eur Neurol; 1987; 26 Suppl 1():2-10. PubMed ID: 3556187
[TBL] [Abstract][Full Text] [Related]
60. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Nakagawa-Hattori Y; Mochizuki H; Tanaka M; Ozawa T
Biochim Biophys Acta; 1995 May; 1271(1):265-74. PubMed ID: 7599219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
